本頁面由Tiger Trade Technology Pte. Ltd.提供服務

神經分泌生物科學

149.50
-0.5200-0.35%
盤前151.001.50+1.00%08:10 EDT
成交量:101.58萬
成交額:1.52億
市值:152.49億
市盈率:21.91
高:151.31
開:150.34
低:149.00
收:150.02
52周最高:186.12
52周最低:122.14
股本:1.02億
流通股本:9,999.56萬
量比:1.03
換手率:1.02%
股息:- -
股息率:- -
每股收益(TTM):6.82
每股收益(LYR):4.67
淨資產收益率:22.09%
總資產收益率:11.70%
市淨率:4.13
市盈率(LYR):32.01

資料載入中...

2026/05/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/18

重要事件披露

Form 8-K - Current report
2026/05/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/05

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/05

重要事件披露

Form 8-K - Current report
2026/04/30

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/06

重要事件披露

Form 8-K - Current report
2026/02/11

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/11

重要事件披露

Form 8-K - Current report
2026/01/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/24

重要事件披露

Form 8-K - Current report
2025/11/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/28

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]